Table 3.

Antibiotic susceptibility of detected carbapenemase-positive nosocomial infections.

Antibiotic	Susceptibility	Infection n (%)
		Pneumonia	UTI	CNS infection	Wound infection
Ceftazidime	S	1 (1)	1 (2.9)	1 (10)	0
	I	0	1 (2.9)	0	0
	R	100 (99)	33 (94.2)	9 (90)	2 (100)
Cefepime	S	1 (0.9)	1 (3)	0	0
	I	3 (2.7)	0	0	0
	R	108 (96.4)	35 (97)	10 (100)	2 (100)
Piperacillin/tazobactam	S	0	1 (3.6)	0	1 (100)
	I	0	0	0	0
	R	39 (100)	27 (96.4)	5 (100)	0
Ampicillin/sulbactam	S	6 (9.5)	0	0	0
	I	1 (1.6)	0	1 (20)	0
	R	56 (88.9)	8 (100)	4 (80)	1 (100)
Ciprofloxacin	S	0	2 (7.4)	0	1 (100)
	I	0	1 (3.7)	0	0
	R	35 (100)	24 (88.9)	5 (100)	0
Levofloxacin	S	0	0	0	0
	I	0	0	0	0
	R	65 (100)	9 (100)	5 (100)	1 (100)
Amikacin	S	9 (8.8)	4 (11.1)	2 (20)	0
	I	0	1 (2.8)	0	1 (50)
	R	93 (91.2)	31 (86.1)	8 (80)	1 (50)
Co-trimoxazole	S	12 (12.1)	8 (25.8)	1 (11.1)	0
	I	1 (1)	1 (3.2)	0	0
	R	86 (86.9)	22 (71)	8 (88.9)	2 (100)
Colistin	S	23 (22.5)	13 (36.1)	3 (27.3)	2 (50)
	I	0	0	0	0
	R	79 (77.5)	23 (63.9)	8 (72.7)	2 (50)